Erik S. Knudsen
Affiliations: | University of Cincinnati, Cincinnati, OH |
Area:
Cell Biology, Molecular BiologyGoogle:
"Erik Knudsen"Children
Sign in to add traineeMatthew W. Strobeck | grad student | 2002 | University of Cincinnati |
Steven P. Angus | grad student | 2003 | University of Cincinnati |
Hasan Siddiqui | grad student | 2006 | University of Cincinnati |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kumarasamy V, Wang J, Frangou C, et al. (2024) The extracellular niche and tumor microenvironment enhance KRAS inhibitor efficacy in pancreatic cancer. Cancer Research |
Knudsen ES, Witkiewicz AK, Rubin SM. (2023) Cancer takes many paths through G1/S. Trends in Cell Biology |
Kumarasamy V, Gao Z, Zhao B, et al. (2023) PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies. British Journal of Cancer |
Kumarasamy V, Frangou C, Wang J, et al. (2023) Pharmacologically targeting KRAS in PDAC models: tumor cell intrinsic and extrinsic impact. Biorxiv : the Preprint Server For Biology |
Witkiewicz AK, Kumarasamy V, Sanidas I, et al. (2022) Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy. Trends in Cancer |
Knudsen ES, Kumarasamy V, Nambiar R, et al. (2022) CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities. Cell Reports. 38: 110448 |
Kumarasamy V, Vail P, Nambiar R, et al. (2020) Functional determinants of cell-cycle plasticity and sensitivity to CDK4/6 inhibition. Cancer Research |
Braden WA, Lenihan JM, Lan Z, et al. (2020) Retraction for Braden et al., "Distinct Action of the Retinoblastoma Pathway on the DNA Replication Machinery Defines Specific Roles for Cyclin-Dependent Kinase Complexes in Prereplication Complex Assembly and S-Phase Progression". Molecular and Cellular Biology. 40 |
Roberts PJ, Kumarasamy V, Witkiewicz AK, et al. (2020) Chemotherapy and CDK4/6 inhibitors: Unexpected bedfellows. Molecular Cancer Therapeutics |
Knudsen ES, Nambiar R, Rosario SR, et al. (2020) Pan-cancer molecular analysis of the RB tumor suppressor pathway. Communications Biology. 3: 158 |